Nasdaq: XLRN

Acceleron Pharma

Acceleron Pharma is a clinical biotechnology company focused on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-β) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. The TGF-β superfamily ligands and their receptors represent a diverse and under-explored set of drug targets with the potential to yield therapeutics that modulate the growth and repair of diseased cells and tissues.